GDG: Applying Deep Learning in Genomics

Applying Deep Learning in Genomics

About this event

The ability to sequence and understand the genome is essential to diagnose critical genetic diseases, which affect roughly 6% of individuals, as well as understand the broad contributions of genetics to health outcomes.

In this session, we will unpack the tech stack behind the breakthroughs of AI in the genomics space, with:

  • DeepConsensus, a Google-developed method which helps instruments to accurately read the genome by removing sequencing errors. We’ll explore how this accurate sequencing helps genome assembly, including the first complete assembly of the human reference genome.
  • DeepVariant, a Google-developed method which identifies genetic variants in individuals, with an example of identifying a disease-causing variant in less than 8 hours to result in life-saving treatment in the Neonatal Intensive Care Unit.
  • How Google is using AI to help build Pangenome References, which are a new way to build reference genomes of individuals from many ancestries to improve the accuracy of genomic analyses for everyone in the world.
  • How Google is applying these tools beyond human analysis to create reference genomes for important and endangered species throughout the world.

Great for research and PhD students, bioinformaticians, computer scientists, plus industry and academic professionals looking to stay at the cutting edge of genomics.

This is a rare opportunity to engage in conversation directly with the architects of Google’s Genomic AI tools. As our speaker is donating their time to be with us, we want to ensure a full and engaged event. Please reserve your spot only if you are committed to joining us for this special deep-dive.

Event Details
  • Start Date
    April 1, 2026 10:00 AM
  • End Date
    April 1, 2026 11:00 AM
  • Status
    Expired
  • Organizer
Andrew Carroll
Product Lead, Genomics
Google AI
The Genomics team in Google AI develops methods to help understand genomic data and combine it with non-genomic biomedical data. Our team builds DeepVariant, a highly accurate deep learning variant caller. The real world applications are in improving clinical genomics, drug discovery, and in non-human biotechnology. Andrew shapes product strategy to drive adoption of the technology and ensure its connection to high-value application. His role has a strong focus on genomics community engagement, collaboration, and partnership. Prior to Google, Andrew was Chief Scientific Officer at DNAnexus, where he grew and led a team of bioinformaticians who supported many of the first large-scale genomics projects, such as the CHARGE Consortium, Regeneron-Gesinger and Regeneron-UKBiobank cohorts, the 3000 Rice Genomes Project, PrecisionFDA, and the St. Jude Pediatric Cancer Cloud. Andrew holds a PhD in Molecular Biology from Stanford University and a Bachelor’s degree in Physics from the University of Virginia.
Event Details
  • Start Date
    April 1, 2026 10:00 AM
  • End Date
    April 1, 2026 11:00 AM
  • Status
    Expired
  • Organizer
Event Tags
Share This Event